1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. CONTINUOUS GLUCOSE MONITORING (CGM) MARKET BY COMPONENT
4.1. Introduction
4.2. Sensors
4.3. Transmitters
4.4. Receivers
4.5. Integrated Insulin Pumps
5. CONTINUOUS GLUCOSE MONITORING (CGM) MARKET BY PRODUCT TYPE
5.1. Introduction
5.2. Wearable
5.3. Implantable
6. CONTINUOUS GLUCOSE MONITORING (CGM) MARKET BY APPLICATION
6.1. Introduction
6.2. Diabetes Patients
6.3. Critical Patients
7. CONTINUOUS GLUCOSE MONITORING (CGM) MARKET BY END-USER INDUSTRY
7.1. Introduction
7.2. Hospitals
7.3. Diagnostic Centers & Clinics
7.4. Home Care
7.5. Others
8. CONTINUOUS GLUCOSE MONITORING (CGM) MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. Israel
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. Japan
8.6.3. India
8.6.4. South Korea
8.6.5. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Abbott Laboratories
10.2. DexCom, Inc.
10.3. Medtronic Plc
10.4. F. Hoffmann-La Roche AG
10.5. Senseonics Holdings, Inc.